(SZU) Südzucker - Ratings and Ratios
Sugar, Starch, Fruit, Bioethanol, Animal Feed
SZU EPS (Earnings per Share)
SZU Revenue
Description: SZU Südzucker
Südzucker AG is a German-based company operating in the Packaged Foods & Meats sub-industry, with a market capitalization of approximately €2.03 billion. The companys stock is listed on XETRA under the ticker symbol SZU.
The negative Return on Equity (RoE) of -5.76% indicates that the company has been generating losses, which may be a concern for investors. However, the forward Price-to-Earnings (P/E) ratio of 15.97 suggests that the market expects the company to return to profitability in the future.
As a major player in the packaged foods industry, Südzucker AGs performance is likely influenced by key economic drivers such as consumer demand, commodity prices, and competition. The companys ability to manage costs, maintain pricing power, and innovate its product portfolio will be crucial in driving future profitability.
To evaluate the investment potential of Südzucker AG, it is essential to monitor key performance indicators (KPIs) such as revenue growth, gross margin, and operating cash flow. Additionally, analyzing the companys debt-to-equity ratio, interest coverage, and other financial metrics will provide insights into its financial health and ability to navigate challenging market conditions.
From a quarterly tax provision perspective, investors should focus on understanding the drivers behind any changes in tax expenses and how they impact the companys bottom line. A thorough analysis of the companys tax strategy and its implications on profitability will be essential in making informed investment decisions.
SZU Stock Overview
| Market Cap in USD | 2,336m |
| Sub-Industry | Packaged Foods & Meats |
| IPO / Inception |
SZU Stock Ratings
| Growth Rating | -19.5% |
| Fundamental | 40.9% |
| Dividend Rating | 47.7% |
| Return 12m vs S&P 500 | -27.1% |
| Analyst Rating | - |
SZU Dividends
| Dividend Yield 12m | 1.96% |
| Yield on Cost 5y | 1.41% |
| Annual Growth 5y | 35.10% |
| Payout Consistency | 89.7% |
| Payout Ratio | 409.1% |
SZU Growth Ratios
| Growth Correlation 3m | -71.8% |
| Growth Correlation 12m | -26.4% |
| Growth Correlation 5y | 2.2% |
| CAGR 5y | -3.83% |
| CAGR/Max DD 3y | -0.09 |
| CAGR/Mean DD 3y | -0.15 |
| Sharpe Ratio 12m | -0.24 |
| Alpha | 0.31 |
| Beta | 0.246 |
| Volatility | 21.02% |
| Current Volume | 89.4k |
| Average Volume 20d | 118.1k |
| Stop Loss | 9.3 (-3.9%) |
| Signal | 0.35 |
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (-191.0m TTM) > 0 and > 6% of Revenue (6% = 557.8m TTM) |
| FCFTA 0.00 (>2.0%) and ΔFCFTA -7.89pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 22.97% (prev 26.95%; Δ -3.99pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.07 (>3.0%) and CFO 608.0m > Net Income -191.0m (YES >=105%, WARN >=100%) |
| Net Debt (3.47b) to EBITDA (52.0m) ratio: 66.65 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.80 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (204.1m) change vs 12m ago 0.0% (target <= -2.0% for YES) |
| Gross Margin 80.67% (prev 60.17%; Δ 20.50pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 98.37% (prev 106.9%; Δ -8.53pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -1.55 (EBITDA TTM 52.0m / Interest Expense TTM 119.0m) >= 6 (WARN >= 3) |
Altman Z'' 2.19
| (A) 0.23 = (Total Current Assets 4.80b - Total Current Liabilities 2.67b) / Total Assets 9.24b |
| (B) 0.09 = Retained Earnings (Balance) 859.0m / Total Assets 9.24b |
| (C) -0.02 = EBIT TTM -184.0m / Avg Total Assets 9.45b |
| (D) 0.48 = Book Value of Equity 2.52b / Total Liabilities 5.28b |
| Total Rating: 2.19 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 40.85
| 1. Piotroski 4.0pt = -1.0 |
| 2. FCF Yield 0.61% = 0.30 |
| 3. FCF Margin 0.34% = 0.09 |
| 4. Debt/Equity 1.21 = 1.81 |
| 5. Debt/Ebitda 75.12 = -2.50 |
| 6. ROIC - WACC data missing |
| 7. RoE -5.76% = -0.96 |
| 8. Rev. Trend -39.95% = -3.00 |
| 9. EPS Trend -77.85% = -3.89 |
What is the price of SZU shares?
Over the past week, the price has changed by -1.93%, over one month by -4.02%, over three months by -12.32% and over the past year by -13.62%.
Is Südzucker a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SZU is around 8.94 EUR . This means that SZU is currently overvalued and has a potential downside of -7.64%.
Is SZU a buy, sell or hold?
What are the forecasts/targets for the SZU price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 10.7 | 10.5% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 9.8 | 1.5% |
SZU Fundamental Data Overview
Market Cap EUR = 1.98b (1.98b EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = 626.0m EUR (last fiscal year)
P/E Forward = 15.9744
P/S = 0.2127
P/B = 0.6145
P/EG = 0.75
Beta = 0.226
Revenue TTM = 9.30b EUR
EBIT TTM = -184.0m EUR
EBITDA TTM = 52.0m EUR
Long Term Debt = 2.62b EUR (from nonCurrentLiabilitiesTotal, last quarter)
Short Term Debt = 1.29b EUR (from shortTermDebt, last quarter)
Debt = 3.91b EUR (Calculated: Short Term 1.29b + Long Term 2.62b)
Net Debt = 3.47b EUR (from netDebt column, last quarter)
Enterprise Value = 5.26b EUR (1.98b + Debt 3.91b - CCE 626.0m)
Interest Coverage Ratio = -1.55 (Ebit TTM -184.0m / Interest Expense TTM 119.0m)
FCF Yield = 0.61% (FCF TTM 32.0m / Enterprise Value 5.26b)
FCF Margin = 0.34% (FCF TTM 32.0m / Revenue TTM 9.30b)
Net Margin = -2.05% (Net Income TTM -191.0m / Revenue TTM 9.30b)
Gross Margin = 80.67% ((Revenue TTM 9.30b - Cost of Revenue TTM 1.80b) / Revenue TTM)
Tobins Q-Ratio = 2.09 (Enterprise Value 5.26b / Book Value Of Equity 2.52b)
Interest Expense / Debt = 0.82% (Interest Expense 32.0m / Debt 3.91b)
Taxrate = unknown
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 1.80 (Total Current Assets 4.80b / Total Current Liabilities 2.67b)
Debt / Equity = 1.21 (Debt 3.91b / last Quarter total Stockholder Equity 3.23b)
Debt / EBITDA = 75.12 (Net Debt 3.47b / EBITDA 52.0m)
Debt / FCF = 122.1 (Debt 3.91b / FCF TTM 32.0m)
Total Stockholder Equity = 3.32b (last 4 quarters mean)
RoA = -2.07% (Net Income -191.0m, Total Assets 9.24b )
RoE = -5.76% (Net Income TTM -191.0m / Total Stockholder Equity 3.32b)
RoCE = -3.10% (Ebit -184.0m / (Equity 3.32b + L.T.Debt 2.62b))
RoIC = unknown (NOPAT none, Invested Capital 4.46b, Ebit -184.0m)
WACC = unknown (E(1.98b)/V(5.88b) * Re(6.92%)) + (D(3.91b)/V(5.88b) * Rd(0.82%) * (1-Tc(none)))
Shares Correlation 3-Years: -20.83 | Cagr: -0.05%
Discount Rate = 6.92% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 70.46% ; FCFE base≈337.2m ; Y1≈221.4m ; Y5≈101.2m
Fair Price DCF = 9.75 (DCF Value 1.99b / Shares Outstanding 204.1m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -77.85 | EPS CAGR: -23.18% | SUE: -4.0 | # QB: 0
Revenue Correlation: -39.95 | Revenue CAGR: -3.12% | SUE: N/A | # QB: None